Objectives: Pompe disease is a rare genetic disease produced by mutations in the GAA gene leading to progressive skeletal and respiratory muscle weakness. T1-weighted magnetic resonance imaging is useful to identify fatty replacement in skeletal muscles of late-onset Pompe disease (LOPD) patients. Previous studies have shown that replacement by fat correlates with worse results of muscle function tests. Our aim was to investigate if fat replacement of muscles involved in the ventilation process correlated with results of the spirometry and predicted respiratory muscle impairment in LOPD patients over time. Materials and Methods: We studied a cohort of 36 LOPD patients followed up annually in our center for a period of 4 years. We quantified...
BACKGROUND: Diaphragm weakness is the main reason for respiratory dysfunction in patients with Pomp...
Background: Late-onset Pompe disease (LOPD) is an autosomal-recessive metabolic myopathy caused by d...
Late-onset Pompe disease(LOPD) is characterized by declining proximal muscle strength and respirator...
Background: Pompe disease is a progressive metabolic myopathy. Involvement of respiratory muscles le...
Background: In Pompe disease, an inherited metabolic muscle disorder, severe diaphragmatic weakness ...
Late onset Pompe disease (LOPD) is a slow, progressive disorder characterized by skeletal and respir...
Altres ajuts: This investigation was sponsored by the following grants, one from Sanofi Genzyme and ...
Objectives To evaluate changes in diaphragmatic function in Pompe disease using MRI over time, both ...
Enzyme replacement therapy has shown to be effective for childhood/adult onset Pompe disease (AOPD)....
Enzyme replacement therapy has shown to be effective for childhood/adult onset Pompe disease (AOPD)....
Background: Diaphragm weakness is the main reason for respiratory dysfunction in patients with Pompe...
The aim of this exploratory study was to evaluate diaphragmatic function across various neuromuscula...
OBJECTIVE: The objective of this study was to evaluate a quantitative method based on conventional ...
Altres ajuts: Sanofi GenzymeObjectives: Magnetization transfer (MT) imaging exploits the interaction...
BACKGROUND: Diaphragm weakness is the main reason for respiratory dysfunction in patients with Pomp...
Background: Late-onset Pompe disease (LOPD) is an autosomal-recessive metabolic myopathy caused by d...
Late-onset Pompe disease(LOPD) is characterized by declining proximal muscle strength and respirator...
Background: Pompe disease is a progressive metabolic myopathy. Involvement of respiratory muscles le...
Background: In Pompe disease, an inherited metabolic muscle disorder, severe diaphragmatic weakness ...
Late onset Pompe disease (LOPD) is a slow, progressive disorder characterized by skeletal and respir...
Altres ajuts: This investigation was sponsored by the following grants, one from Sanofi Genzyme and ...
Objectives To evaluate changes in diaphragmatic function in Pompe disease using MRI over time, both ...
Enzyme replacement therapy has shown to be effective for childhood/adult onset Pompe disease (AOPD)....
Enzyme replacement therapy has shown to be effective for childhood/adult onset Pompe disease (AOPD)....
Background: Diaphragm weakness is the main reason for respiratory dysfunction in patients with Pompe...
The aim of this exploratory study was to evaluate diaphragmatic function across various neuromuscula...
OBJECTIVE: The objective of this study was to evaluate a quantitative method based on conventional ...
Altres ajuts: Sanofi GenzymeObjectives: Magnetization transfer (MT) imaging exploits the interaction...
BACKGROUND: Diaphragm weakness is the main reason for respiratory dysfunction in patients with Pomp...
Background: Late-onset Pompe disease (LOPD) is an autosomal-recessive metabolic myopathy caused by d...
Late-onset Pompe disease(LOPD) is characterized by declining proximal muscle strength and respirator...